» Articles » PMID: 16184434

Design of Recombinant Stem Cell Factor-macrophage Colony Stimulating Factor Fusion Proteins and Their Biological Activity in Vitro

Overview
Publisher Springer
Date 2005 Sep 27
PMID 16184434
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cell factor (SCF) and macrophage colony stimulating factor (M-CSF) can act in synergistic way to promote the growth of mononuclear phagocytes. SCF-M-CSF fusion proteins were designed on the computer using the Homology and Biopolymer modules of the software packages InsightII. Several existing crystal structures were used as templates to generate models of the complexes of receptor with fusion protein. The structure rationality of the fusion protein incorporated a series of flexible linker peptide was analyzed on InsightII system. Then, a suitable peptide GGGGSGGGGSGG was chosen for the fusion protein. Two recombinant SCF-M-CSF fusion proteins were generated by construction of a plasmid in which the coding regions of human SCF (1-165aa) and M-CSF (1-149aa) cDNA were connected by this linker peptide coding sequence followed by subsequent expression in insect cell. The results of Western blot and activity analysis showed that these two recombinant fusion proteins existed as a dimer with a molecular weight of approximately 84 KD under non-reducing conditions and a monomer of approximately 42 KD at reducing condition. The results of cell proliferation assays showed that each fusion protein induced a dose-dependent proliferative response. At equimolar concentration, SCF/M-CSF was about 20 times more potent than the standard monomeric SCF in stimulating TF-1 cell line growth, while M-CSF/SCF was 10 times of monomeric SCF. No activity difference of M-CSF/SCF or SCF/M-CSF to M-CSF (at same molar) was found in stimulating the HL-60 cell linear growth. The synergistic effect of SCF and M-CSF moieties in the fusion proteins was demonstrated by the result of clonogenic assay performed with human bone mononuclear, in which both SCF/M-CSF and M-CSF/SCF induced much higher number of CFU-M than equimolar amount of SCF or M-CSF or that of two cytokines mixture.

Citing Articles

SNAP-Tag Technology: A Promising Tool for Ex Vivo Immunophenotyping.

Choudhary S, Barth S, Verma R Mol Diagn Ther. 2017; 21(3):315-326.

PMID: 28164252 DOI: 10.1007/s40291-017-0263-2.


Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells.

He K, Qu H, Xu L, Gao J, Cheng F, Xiang P Biosci Rep. 2016; 36(5).

PMID: 27377320 PMC: 5025808. DOI: 10.1042/BSR20160104.

References
1.
Difalco M, Congote L . Preparation of a recombinant chimaera of insulin-like growth factor II and interleukin 3 with high proliferative potency for haemopoietic cells. Biochem J. 1997; 326 ( Pt 2):407-13. PMC: 1218685. DOI: 10.1042/bj3260407. View

2.
McNiece I, Briddell R . Stem cell factor. J Leukoc Biol. 1995; 58(1):14-22. DOI: 10.1002/jlb.58.1.14. View

3.
Yang J, Liu C . Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120. Acta Pharmacol Sin. 2001; 21(1):29-34. View

4.
Landar A, Curry B, Parker M, Digiacomo R, Indelicato S, Nagabhushan T . Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma. J Mol Biol. 2000; 299(1):169-79. DOI: 10.1006/jmbi.2000.3734. View

5.
Philo J, Wen J, Wypych J, Schwartz M, Mendiaz E, Langley K . Human stem cell factor dimer forms a complex with two molecules of the extracellular domain of its receptor, Kit. J Biol Chem. 1996; 271(12):6895-902. DOI: 10.1074/jbc.271.12.6895. View